Inventor
CASTRO RYAN O
US7 patents
⚠️ This page may combine multiple inventors who share the name “CASTRO RYAN O”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARENA PHARM INC
5 patentsUS11091435B2Aug 17, 2021
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in S1P1 receptor-associated disorders
ARENA PHARM INC11 citations93
US10676435B2Jun 9, 2020
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound 1) for use in SIPI receptor-associated disorders
ARENA PHARM INC12 citations93
US10301262B2May 28, 2019
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders
ARENA PHARM INC11 citations91
US11884626B2Jan 30, 2024
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1P1 receptor-associated disorders
ARENA PHARM INC3 citations73
US12378198B2Aug 5, 2025
Crystalline l-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in SIPI receptor-associated disorders
ARENA PHARM INC0 citations61